Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus

Search Close Search
Page Menu

Li Zhong

 

 

 

 

UMassMed Faculty Page

Inventions:

Title: Critical Amino Acid Residues Contribute to Crossing Vascular Barrier by AAV9 Vector. UMMS12-73; Patent Pending.

  • New rAAV vector technology desirable for gene therapy applications addressing muscular and lung disorders. A novel AAV9 capsid mutant produces local tissue-restricted expression and genome persistence, delivered by intravascular (IV), intramuscular (IM) and intranasal (IN) route. The therapy is effective while producing low levels of expression in liver. 

 

Innovation TopicsGene TherapyAAVGene therapy improvementGene editing